MD Anderson and ARTIDIS Announce Strategic Alliance to Advance Nanomechanical Technology Platform for Optimizing Cancer Treatment
03 oct. 2022 09h05 HE
|
ARTIDIS AG
HOUSTON and BASEL, Switzerland, Oct. 03, 2022 (GLOBE NEWSWIRE) -- ARTIDIS AG, the developer of the first nanomechanical technology platform for tissue analytics, and The University of Texas MD...
Mission Cure Holdings, Path BioAnalytics and Ariel Precision Medicine, Launch Unique Research Alliance to Advance Treatments for Pancreatitis
15 juin 2020 08h00 HE
|
Ariel Precision Medicine
New York; Chapel Hill, NC; Pittsburgh, June 15, 2020 (GLOBE NEWSWIRE) -- Mission Cure Holdings, LLC, Path BioAnalytics, Inc. and Ariel Precision Medicine, Inc. jointly announced the creation of a...